Investing Activities

Debt securities

The following tables present the debt securities available-for-sale by sector held at March 31, 2013 and December 31, 2012, respectively. The unrealized loss amounts presented below include the non-credit loss component of OTTI losses. We classify these investments into various sectors in line with industry conventions.



Fair Value and Cost of Securities:	March 31, 2013
($ in millions)	Amortized Cost		Gross Unrealized Gains [1]		Gross Unrealized Losses [1]			Fair Value		OTTI Recognized in AOCI [2]

U.S. government and agency	$	41.1	$	4.9	$	(0.4	)	$	45.6	$	—
State and political subdivision	106.2		11.2		(0.3		)	117.1		(0.2		)
Foreign government	44.4		5.7		—			50.1		—
Corporate	1,908.2		140.3		(23.0		)	2,025.5		(1.5		)
Commercial mortgage-backed (“CMBS”)	225.2		24.1		(0.6		)	248.7		(0.6		)
Residential mortgage-backed (“RMBS”)	384.9		16.6		(5.5		)	396.0		(8.6		)
CDO/CLO	63.0		1.8		(2.6		)	62.2		(3.0		)
Other asset-backed	109.4		6.0		(5.9		)	109.5		—
Available-for-sale debt securities	$	2,882.4	$	210.6	$	(38.3	)	$	3,054.7	$	(13.9	)

———————


[1]	Net unrealized investment gains and losses on securities classified as available-for-sale and certain other assets are included in our balance sheets as a component of AOCI.


[2]	Represents the amount of non-credit OTTI losses recognized in AOCI excluding net unrealized gains or losses subsequent to the date of impairment. The table above presents the special category of AOCI for debt securities that are other-than-temporarily impaired when the impairment loss has been split between the credit loss component (in earnings) and the non-credit component.



Fair Value and Cost of Securities:	December 31, 2012
($ in millions)
	Amortized Cost		Gross Unrealized Gains [1]		Gross Unrealized Losses [1]			Fair Value		OTTI Recognized in AOCI [2]

U.S. government and agency	$	35.8	$	4.8	$	(0.4	)	$	40.2	$	—
State and political subdivision	120.5		10.9		(0.5		)	130.9		(0.2		)
Foreign government	44.4		7.4		—			51.8		—
Corporate	1,776.9		144.6		(24.0		)	1,897.5		(1.5		)
CMBS	229.6		26.0		(1.6		)	254.0		(0.6		)
RMBS	412.6		17.5		(7.6		)	422.5		(9.0		)
CDO/CLO	59.2		1.8		(4.2		)	56.8		(3.3		)
Other asset-backed	119.1		6.0		(6.5		)	118.6		—
Available-for-sale debt securities	$	2,798.1	$	219.0	$	(44.8	)	$	2,972.3	$	(14.6	)

———————


[1]	Net unrealized investment gains and losses on securities classified as available-for-sale and certain other assets are included in our balance sheets as a component of AOCI.


[2]	Represents the amount of non-credit OTTI losses recognized in AOCI excluding net unrealized gains or losses subsequent to the date of impairment. The table above presents the special category of AOCI for debt securities that are other-than-temporarily impaired when the impairment loss has been split between the credit loss component (in earnings) and the non-credit component.



Maturities of Debt Securities:	March 31, 2013
($ in millions)	Amortized Cost		Fair Value

Due in one year or less	$	46.2	$	47.1
Due after one year through five years	125.4		137.1
Due after five years through ten years	263.9		284.4
Due after ten years	1,664.4		1,769.7
CMBS/RMBS/ABS/CDO/CLO [1]	782.5		816.4
Total	$	2,882.4	$	3,054.7

———————


[1]	CMBS, RMBS, ABS, CDO and CLO are not listed separately in the table as each security does not have a single fixed maturity.

The maturities of debt securities, as of March 31, 2013, are summarized in the table above by contractual maturity. Actual maturities may differ from contractual maturities as certain borrowers have the right to call or prepay obligations with or without call or prepayment penalties, and we have the right to put or sell certain obligations back to the issuers.

The following table depicts the sources of available-for-sale investment proceeds and related investment gains (losses).



Sales of Available-for-Sale Securities:
($ in millions)	March 31, 2013			December 31, 2012
Debt securities, available-for-sale
Proceeds from sales	$	0.2		$	160.0
Proceeds from maturities/repayments	57.1			285.3
Gross investment gains from sales, prepayments and maturities	5.2			22.8
Gross investment losses from sales and maturities	(0.1		)	(0.7		)



	As of
Aging of Temporarily Impaired	March 31, 2013
Debt Securities:	Less than 12 months					Greater than 12 months					Total
($ in millions)	Fair Value		Unrealized Losses			Fair Value		Unrealized Losses			Fair Value		Unrealized Losses
Debt Securities
U.S. government and agency	$	—	$	—		$	3.5	$	(0.4	)	$	3.5	$	(0.4	)
State and political subdivision	4.8		(0.3		)	—		—			4.8		(0.3		)
Foreign government	1.0		—			—		—			1.0		—
Corporate	180.0		(3.0		)	65.1		(20.0		)	245.1		(23.0		)
CMBS	4.5		—			7.4		(0.6		)	11.9		(0.6		)
RMBS	20.6		(0.3		)	47.1		(5.2		)	67.7		(5.5		)
CDO/CLO	5.7		(0.1		)	32.9		(2.5		)	38.6		(2.6		)
Other asset-backed	3.5		(0.3		)	12.4		(5.6		)	15.9		(5.9		)
Total temporarily impaired securities	$	220.1	$	(4.0	)	$	168.4	$	(34.3	)	$	388.5	$	(38.3	)
Below investment grade	$	6.0	$	(0.2	)	$	66.8	$	(20.5	)	$	72.8	$	(20.7	)
Number of securities			72					79					151

Unrealized losses on below-investment-grade debt securities with a fair value depressed by more than 20% of amortized cost totaled $16.7 million at March 31, 2013, of which $16.7 million was depressed by more than 20% of amortized cost for more than 12 months.

These securities were considered to be temporarily impaired at March 31, 2013 because each of these securities had performed, and are expected to perform, in accordance with original contractual terms. In addition, management does not have the intention to sell nor does it expect to be required to sell these securities prior to their recovery.



Aging of Temporarily Impaired	December 31, 2012
Debt Securities:	Less than 12 months					Greater than 12 months					Total
($ in millions)	Fair Value		Unrealized Losses			Fair Value		Unrealized Losses			Fair Value		Unrealized Losses
Debt Securities
U.S. government and agency	$	—	$	—		$	3.5	(0.4		)	$	3.5	$	(0.4	)
State and political subdivision	4.8		(0.3		)	1.0		(0.2		)	5.8		(0.5		)
Foreign government	—		—			—		—			—		—
Corporate	114.5		(1.7		)	64.7		(22.3		)	179.2		(24.0		)
CMBS	0.7		(0.1		)	10.6		(1.5		)	11.3		(1.6		)
RMBS	24.1		(0.2		)	52.6		(7.4		)	76.7		(7.6		)
CDO/CLO	—		—			39.0		(4.2		)	39.0		(4.2		)
Other asset-backed	0.9		—			10.7		(6.5		)	11.6		(6.5		)
Total temporarily impaired securities	$	145.0	$	(2.3	)	$	182.1	$	(42.5	)	$	327.1	$	(44.8	)
Below investment grade	$	7.8	$	(0.5	)	$	63.4	$	(25.4	)	$	71.2	$	(25.9	)
Number of securities			48					89					137

Unrealized losses on below-investment-grade debt securities with a fair value depressed by more than 20% of amortized cost totaled $21.6 million at December 31, 2012, of which $21.6 million was depressed by more than 20% of amortized cost for more than 12 months.

These securities were considered to be temporarily impaired at December 31, 2012 because each of these securities had performed, and are expected to perform, in accordance with original contractual terms. In addition, management does not have the intention to sell nor does it expect to be required to sell these securities prior to their recovery.

Evaluating temporarily impaired available-for-sale securities

In management’s evaluation of temporarily impaired securities, many factors about individual issuers of securities as well as our best judgment in determining the cause of a decline in the estimated fair value are considered in the assessment of potential near-term recovery in the security’s value. Some of those considerations include, but are not limited to: (i) duration of time and extent to which the estimated fair value has been below cost or amortized cost; (ii) for debt securities, if the Company has the intent to sell or will more likely than not be required to sell a particular security before the decline in estimated fair value below amortized cost recovers; (iii) whether the issuer is experiencing significant financial difficulties and the potential for impairments of that issuer’s securities; (iv) pervasive issues across an entire industry sector/sub-sector; and (v) for structured securities, assessing any changes in the forecasted cash flows, the quality of underlying collateral, expectations of prepayment speeds, loss severity and payment priority of tranches held.

Other-than-temporary impairments

Management assessed all securities in an unrealized loss position in determining whether impairments were temporary or other-than-temporary. In reaching its conclusions, management exercised significant judgment and used a number of issuer-specific quantitative indicators and qualitative judgments to assess the probability of receiving a given security’s contractual cash flows. This included the issue’s implied yield to maturity, cumulative default rate based on rating, comparisons of issue-specific spreads to industry or sector spreads, specific trading activity in the issue, and other market data such as recent debt tenders and upcoming refinancing requirements. Management also reviewed fundamentals such as issuer credit and liquidity metrics, business outlook and industry conditions. Management maintains a watch list of securities that is reviewed for impairments. Each security on the watch list was evaluated, analyzed and discussed, with the positive and negative factors weighed in the ultimate determination of whether or not the security was other-than-temporarily impaired. For securities for which no OTTI was ultimately indicated at March 31, 2013, management does not have the intention to sell, nor does it expect to be required to sell, these securities prior to their recovery.

OTTIs recorded on available-for-sale debt securities in the first three months of 2013 were primarily concentrated in structured securities. These impairments were driven primarily by increased collateral default rates. In our judgment, these credit events or other adverse conditions of the collateral have caused, or will most likely lead to, a deficiency in the contractual cash flows related to the investment. Therefore, based upon these credit events, we have determined that OTTIs exist. Total debt impairments recognized through earnings related to such credit-related circumstances were $1.0 million for the first quarter of 2013 and $1.0 million for the first quarter of 2012. There were no limited partnerships and other investment OTTIs for the three months ended March 31, 2013 and 2012.

In addition to these credit-related impairments recognized through earnings, we impaired securities to fair value through other comprehensive loss for any impairments related to non-credit related factors. These types of impairments were driven primarily by market or sector credit spread widening or by a lack of liquidity in the securities. The amount of impairments recognized as an adjustment to other comprehensive loss due to these factors was $(0.7) million for the first quarter of 2013 and $(0.3) million for the first quarter of 2012.

The following table presents a roll-forward of pre-tax credit losses recognized in earnings related to debt securities for which a portion of the OTTI was recognized in OCI.



Credit Losses Recognized in Earnings on Debt Securities for	Three Months Ended
which a Portion of the OTTI Loss was Recognized in OCI:	March 31,
($ in millions)	2013			2012
				As restated and amended

Balance, beginning of period	$	(17.8	)	$	(21.3	)
Add: Credit losses on securities not previously impaired [1]	—			(0.3		)
Add: Credit losses on securities previously impaired [1]	(0.6		)	(0.5		)
Less: Credit losses on securities impaired due to intent to sell	—			—
Less: Credit losses on securities sold	—			—
Less: Increases in cash flows expected on previously impaired securities	—			—
Balance, end of period	$	(18.4	)	$	(22.1	)

———————


[1]	Additional credit losses on securities for which a portion of the OTTI loss was recognized in AOCI are included within net OTTI losses recognized in earnings on the statements of income and comprehensive income.

Limited partnerships and other investments

Limited partnerships and other investments consist of private equity investments of $5.7 million and $6.7 million as of March 31, 2013 and December 31, 2012, respectively.

Net investment income

Net investment income is comprised primarily of interest income, including amortization of premiums and accretion of discounts on structured securities, based on yields which are changed due to expectations in projected principal and interest cash flows, gains and losses on securities measured at fair value and earnings from investments accounted for under the equity method of accounting.



Sources of Net Investment Income:	Three Months Ended
($ in millions)	March 31,
	2013		2012
			As restated and amended

Debt securities [1]	$	31.9	$	29.8
Policy loans	0.7		0.8
Limited partnerships and other investments	0.7		0.1
Fair value investments	0.3		0.3
Total investment income	33.6		31.0
Less: Investment expenses	0.6		0.4
Net investment income	$	33.0	$	30.6

———————


[1]	Includes net investment income on short-term investments.

Net realized investment gains (losses)



Sources and Types of	Three Months Ended
Net Realized Investment Gains (Losses):	March 31,
($ in millions)	2013			2012
				As restated and amended

Total other-than-temporary debt impairments	$	(0.3	)	$	(0.7	)
Portion of loss recognized in OCI	(0.7		)	(0.3		)
Net debt impairments recognized in earnings	$	(1.0	)	$	(1.0	)

Debt security impairments:
U.S. government and agency	$	—		$	—
State and political subdivision	—			—
Foreign government	—			—
Corporate	—			—
CMBS	(0.1		)	(0.1		)
RMBS	(0.7		)	(0.8		)
CDO/CLO	(0.2		)	—
Other asset-backed	—			(0.1		)
Net debt security impairments	(1.0		)	(1.0		)
Equity security impairments	—			—
Impairment losses	(1.0		)	(1.0		)
Debt security transaction gains	5.2			0.3
Debt security transaction losses	(0.1		)	(0.1		)
Limited partnerships and other investment gains	—			—
Limited partnerships and other investment losses	—			—
Net transaction gains (losses)	5.1			0.2
Derivative instruments	(20.9		)	(19.4		)
Embedded derivatives [1]	(0.6		)	23.0
Related party reinsurance derivatives	—			(5.3		)
Net realized investment gains (losses), excluding impairment losses	$	(16.4	)	$	(1.5	)
Net realized investment gains (losses), including impairment losses	$	(17.4	)	$	(2.5	)

———————


[1]	Includes the change in fair value of embedded derivatives associated with fixed index annuity indexed crediting feature and variable annuity GMWB, GMAB and COMBO riders. See Note 8 to these financial statements for additional disclosures.

Unrealized investment gains (losses)



Sources of Changes in	Three Months Ended
Net Unrealized Investment Gains (Losses):	March 31,
($ in millions)	2013			2012
				As restated and amended

Debt securities	$	(1.9	)	$	20.3
Equity securities	—			—
Other investments	—			(0.3		)
Net unrealized investment gains (losses)	$	(1.9	)	$	20.0

Net unrealized investment gains (losses)	$	(1.9	)	$	20.0
Applicable to DAC	(4.2		)	10.7
Applicable to other actuarial offsets	15.6			0.7
Applicable to deferred income tax expense (benefit)	2.7			3.7
Offsets to net unrealized investment gains (losses)	14.1			15.1
Net unrealized investment gains (losses) included in OCI	$	(16.0	)	$	4.9

Non-consolidated variable interest entities

We hold limited partnership interests with various VIEs primarily as a passive investor in private equity limited partnerships and through direct investments, in which the general partners are not related parties. As the Company is not the general partner in any VIE structures, consolidation is based on evaluation of the primary beneficiary. This analysis includes a review of the VIE’s capital structure, nature of the VIE’s operations and purpose and the Company’s involvement with the entity. When determining the need to consolidate a VIE, the design of the VIE is evaluated as well as any exposed risks of the Company’s investment. As we do not have both: (i) the power to direct the activities of the VIE that most significantly impact the economic performance of the entity; and (ii) the obligation to absorb losses of the entity that could be potentially significant to the VIE or the right to receive benefits from the entity that could be potentially significant, we do not consolidate these VIEs. These investments are accounted for under the equity method of accounting and are included in limited partnerships and other investments on our balance sheets. We reassess our VIE determination with respect to an entity on an ongoing basis.

The carrying value of our investments in non-consolidated VIEs (based upon sponsor values and financial statements of the individual entities) for which we are not the primary beneficiary was $8.6 million and $2.1 million as of March 31, 2013 and December 31, 2012, respectively. The maximum exposure to loss is equal to the carrying amounts plus any unfunded commitments of the Company. Such a maximum loss would be expected to occur only upon bankruptcy of the issuer or investee. The Company has not provided nor intends to provide financial support to these entities unless contractually required. We do not have the contractual option to redeem these limited partnership interests but receive distributions based on the liquidation of the underlying assets. The Company must generally request general partner consent to transfer or sell its fund interests. The Company performs ongoing qualitative analysis of its involvement with VIEs to determine if consolidation is required.

In addition, the Company makes passive investments in structured securities issued by VIEs, for which the Company is not the manager, which are included in CMBS, RMBS, CDO/CLO and other asset-backed securities within available-for-sale debt securities, and in fair value investments, in the balance sheets. The Company has not provided financial or other support with respect to these investments other than its original investment. For these investments, the Company determined it is not the primary beneficiary due to the size of our investment relative to the structured securities issued by the VIE, the level of credit subordination which reduces the Company’s obligation to absorb losses or right to receive benefits, and the Company’s lack of power over the activities that most significantly impact the economic performance of the VIEs. The Company’s maximum exposure to loss on these investments is limited to the amount of our investment.

Issuer and counterparty credit exposure

Credit exposure related to issuers and derivatives counterparties is inherent in investments and derivative contracts with positive fair value or asset balances. We manage credit risk through the analysis of the underlying obligors, issuers and transaction structures. We review our debt security portfolio regularly to monitor the performance of obligors and assess the stability of their credit ratings. We also manage credit risk through industry and issuer diversification and asset allocation. Included in fixed maturities are below-investment-grade assets totaling $186.9 million and $182.5 million at March 31, 2013 and December 31, 2012, respectively. Maximum exposure to an issuer or derivative counterparty is defined by quality ratings, with higher quality issuers having larger exposure limits. As of March 31, 2013, we were exposed to the credit concentration risk of two issuers, Goldman Sachs International, and JP Morgan Chase Bank NA, representing exposure greater than 10.0% of stockholder’s equity other than U.S. government and government agencies backed by the faith and credit of the U.S. government. We monitor credit exposures by actively monitoring dollar limits on transactions with specific counterparties. We have an overall limit on below-investment-grade rated issuer exposure. Additionally, the creditworthiness of counterparties is reviewed periodically. We generally use ISDA Master Agreements which include Credit Support Annexes which include collateral provisions to reduce counterparty credit exposures. To further mitigate the risk of loss on derivatives, we only enter into contracts in which the counterparty is a financial institution with a rating of A or higher from at least one Nationally Recognized Statistical Rating Organization.

As of March 31, 2013, we held derivative assets, net of liabilities, with a fair value of $110.2 million. Derivative credit exposure was diversified with 11 different counterparties. We also had debt securities of these counterparties with a fair value of $35.4 million as of March 31, 2013. Our maximum amount of loss due to credit risk with these issuers was $145.6 million as of March 31, 2013. See Note 9 to these financial statements for additional information regarding derivatives.